Equinor ASA vs Edwards Lifesciences Corporation Common Stock — how do they compare? Equinor ASA trades at $43.63 (market cap $101.62B), while Edwards Lifesciences Corporation Common Stock trades at $83.47 (market cap $48.56B). The key difference: Equinor ASA is far larger — about 2.1× Edwards Lifesciences Corporation Common Stock's market cap, and Equinor ASA pays a 3.63% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EQNR | EW | |
|---|---|---|
Market Cap | $101.62B | $48.56B |
Volume | 4,991,782 | 6,520,488 |
Sector | Energy | Health |
52-Week High | $45.75 | $95.18 |
52-Week Low | $22.41 | $72.65 |
Typical Hold Time | 59 Days | — |
Enterprise Value | $110.31B | $45.01B |
Dividend Yield | 3.63% | — |
Signals from Pluang's Aura AI — not financial advice
EQNR trades at $41.61, down 3.26% today, with a bearish technical outlook and mixed fundamental performance. The stock shows attractive valuation metrics including P/E of 11.63 and EV/EBITDA of 2.39, but faces declining profit margins from 19.29% in 2022 to 4.76% in 2025. Recent earnings show two beats and one miss, while analyst consensus remains positive with a $87.50 price target representing significant upside potential from current levels.
The investment case balances deep value characteristics against operational headwinds. While valuation appears compelling with strong cash flows and dividend payments, investors face risks from volatile energy markets and margin compression. The 112% upside to consensus target suggests Wall Street sees substantial recovery potential if operational performance improves.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →